Most of conventional 2-dimensional (2D) methods verify dose of multiple targets separately one-by-one for Single-isocenter Multiple-target (SIMT) brain plans, which are inefficient and sub-optimal. This study presented a practical method to verify the dose of 2 targets simultaneously for improved efficiency and accuracy. Fifteen Stereotactic Radiation Therapy (SRT) and sixteen Stereotactic Radiosurgery (SRS) plans were used for this study. Each plan has 2 targets coincide with a plane through the plan isocenter. All plans were created in the Eclipse Treatment Planning System (TPS) using a 6 MV flattening filter free photon beam. A 2D detector array, myQA SRS was used for measurements. It has a spatial resolution of 0.4 mm and an active area of 120 × 140 mm. It can be rotated along the longitudinal axis with a cylindrical phantom with one-degree precision. All plans were delivered with the detector array centered at the plan isocenter and rotated to intersect 2 targets. Six plans with target separations less than 70 mm were crosschecked with the SRS MapCHECK, which has an active area of 77 × 77 mm. The measured 2D dose distributions were compared with those calculated from the TPS. Gamma-index analysis was performed using 3%/1 mm criteria and a 10% dose threshold. For all 31 SIMT brain plans measured with myQA SRS, the average and standard deviation of the gamma-passing rate was (96.8 ± 2.2)%. For 15 SRT plans and 16 SRS plans, that was (96.6 ± 2.4)% and (97.0 ± 2.1)%, respectively. For 6 plans crosschecked, the average gamma-passing rates were 96.8% vs. 94.8% with myQA SRS and SRS MapCHECK, respectively. A practical method to verify the dose of 2 targets simultaneously was demonstrated. It offers an efficient way for pretreatment verification of SIMT SRT and SRS plans with improved accuracy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.meddos.2024.12.006DOI Listing

Publication Analysis

Top Keywords

targets simultaneously
12
verify dose
12
srs plans
12
myqa srs
12
plans
11
stereotactic radiation
8
radiation therapy
8
simt brain
8
brain plans
8
practical method
8

Similar Publications

Modeling dosimetric benefits from daily adaptive RT for gynecological cancer patients with and without knowledge-based dose prediction.

J Appl Clin Med Phys

January 2025

Department of Radiation Medicine and Applied Sciences, UC San Diego Health, La Jolla, California, USA.

Purpose: Daily online adaptive radiotherapy (ART) improves dose metrics for gynecological cancer patients, but the on-treatment process is resource-intensive requiring longer appointments and additional time from the entire adaptive team. To optimize resource allocation, we propose a model to identify high-priority patients.

Methods: For 49 retrospective cervical and endometrial cancer patients, we calculated two initial plans: the treated standard-of-care (Initial) and a reduced margin initial plan (Initial) for adapting with the Ethos treatment planning system.

View Article and Find Full Text PDF

Integrated Genomics Reveal Potential Resistance Mechanisms of PANoptosis-Associated Genes in Acute Myeloid Leukemia.

Mol Carcinog

January 2025

Institute of Precision Medicine, The First Affiliated Hospital; Department of Pediatrics, The Seventh Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Acute myeloid leukemia (AML) is marked by the proliferation of abnormal myeloid progenitor cells in the bone marrow and blood, leading to low cure rates despite new drug approvals from 2017 to 2018. Current therapies often fail due to the emergence of drug resistance mechanisms, such as those involving anti-apoptotic pathways and immune evasion, highlighting an urgent need for novel approaches to overcome these limitations. Programmed cell death (PCD) is crucial for tissue homeostasis, with PANoptosis-a form of PCD integrating pyroptosis, apoptosis, and necroptosis-recently identified.

View Article and Find Full Text PDF

Purpose Of Review: Proliferative vitreoretinopathy (PVR) is a severe complication of retinal detachment and trauma, posing significant challenges to surgical success and visual prognosis. Despite advancements in vitreoretinal surgery, PVR incidence remains unchanged, this review presents a synthesis of the principal clinical and preclinical research findings from recent years.

Recent Findings: Recent research has focused on anti-inflammatory, antiproliferative, and antifibrotic agents.

View Article and Find Full Text PDF

High drug resistance remains a challenge for chemotherapy against hepatocellular carcinoma (HCC). Combining chemotherapeutic agents with microRNA (miRNA), which simultaneously regulates multiple pathways, offers a promising approach to improve therapeutic efficacy against HCC. Although cationic amphiphilic copolymers have been used to co-deliver these agents, their effectiveness is often limited by low co-encapsulation efficiency and inherent cationic toxicity.

View Article and Find Full Text PDF

Pulmonary sarcomatoid carcinoma (PSC) is a rare non-small-cell lung cancer with sarcomatous components or sarcomatoid differentiation, high degree of malignancy, and insensitivity to chemotherapy or radiotherapy. The management of PSC coexisting with tuberculosis (TB) poses a greater challenge, as it necessitates concurrent administration of both anti-TB and anti-neoplastic therapies. The efficacy of anti-PD-1 immunotherapy in non-small-cell lung cancer is promising, but its safety in patients with co-existent TB remains uncertain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!